Sign in to view content

Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA

W. Lloyd Clark, MD, FASRS

Video
Published 2019

W. Lloyd Clark, MD

Diabetic Retinopathy Part I Symposium

Related

Two years visual acuity and anatomical outcomes of patients with diabetic macular oedema treated with intravitreal aflibercept in a real life setting
Marko Lukic, MD PhD FEBO FASRS
On Demand Cases, Courses, and Papers
2019
Widefield Fluorescein Angiographic-Guided Aflibercept (WFFAGA) Monotherapy for Proliferative Diabetic Retinopathy (PDR)
Dennis M. Marcus, MD
Annual Meeting Talks
2019
Impact of Race on Vision Outcomes in Ranibizumab-Treated Patients With Diabetic Macular Edema: A Meta-Analysis of 5 Clinical Trials
M. Ali Khan, MD, FACS, FASRS
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more